-
Mashup Score: 0Adjuvant Atezolizumab/Bevacizumab Shows Recurrence-Free Survival Benefit Over Active Surveillance in HCC - 1 year(s) ago
Combined adjuvant treatment with atezolizumab and bevacizumab was determined to deliver a statistically significant recurrence-free survival benefit to patients with resected hepatocellular carcinoma.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Stay up to date, maintain your CME with the latest research, author interviews, apps, and learning courses from JAMA and the Specialty Journals.
Source: jamanetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Cancer Moonshot Scholars - 1 year(s) ago
The Cancer Moonshot Scholars program seeks to diversify the NCI R01 portfolio by enhancing the number of applications submitted by Early Stage Investigators from diverse backgrounds, including those from groups identified as underrepresented (NOT-OD-20-031) in the biomedical, clinical, behavioral, and social sciences research workforce.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1AACR Annual Meeting 2023 - 1 year(s) ago
From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy, the AACR Annual Meeting highlights the best minds in cancer research.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0AACR Annual Meeting 2023 - 1 year(s) ago
From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy, the AACR Annual Meeting highlights the best minds in cancer research.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1AACR Annual Meeting 2023 - 1 year(s) ago
From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy, the AACR Annual Meeting highlights the best minds in cancer research.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1AACR Annual Meeting 2023 - 1 year(s) ago
From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy, the AACR Annual Meeting highlights the best minds in cancer research.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3ASCO GU 2023: Practice Changing, Practice Reaffirming, Practice Informing and Emerging Advances - 1 year(s) ago
The ASCO GU symposium was held in San Francisco from February 16-18, 2023. This is a large multidisciplinary conference that brings together GU onc…
Source: opmed.doximity.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The Cancer News Daily - 2 year(s) ago
The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet
Adjuvant Atezolizumab/Bevacizumab Shows Recurrence-Free Survival Benefit Over Active Surveillance in HCC #AACR #HCC #hpbcsm #oncology #nursing #AACR23 https://t.co/F4pdKOelMB